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automation on meta-analyses of diagnostic
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Abstract
Background: The large and increasing number of new studies published each year is making literature identification
in systematic reviews ever more time-consuming and costly. Technological assistance has been suggested as an
alternative to the conventional, manual study identification to mitigate the cost, but previous literature has mainly
evaluated methods in terms of recall (search sensitivity) and workload reduction. There is a need to also evaluate
whether screening prioritization methods leads to the same results and conclusions as exhaustive manual screening.
In this study, we examined the impact of one screening prioritization method based on active learning on sensitivity
and specificity estimates in systematic reviews of diagnostic test accuracy.
Methods: We simulated the screening process in 48 Cochrane reviews of diagnostic test accuracy and re-run 400
meta-analyses based on a least 3 studies. We compared screening prioritization (with technological assistance) and
screening in randomized order (standard practice without technology assistance). We examined if the screening
could have been stopped before identifying all relevant studies while still producing reliable summary estimates. For
all meta-analyses, we also examined the relationship between the number of relevant studies and the reliability of the
final estimates.
Results: The main meta-analysis in each systematic review could have been performed after screening an average of
30% of the candidate articles (range 0.07 to 100%). No systematic review would have required screening more than
2308 studies, whereas manual screening would have required screening up to 43,363 studies. Despite an average 70%
recall, the estimation error would have been 1.3% on average, compared to an average 2% estimation error expected
when replicating summary estimate calculations.
Conclusion: Screening prioritization coupled with stopping criteria in diagnostic test accuracy reviews can reliably
detect when the screening process has identified a sufficient number of studies to perform the main meta-analysis
with an accuracy within pre-specified tolerance limits. However, many of the systematic reviews did not identify a
sufficient number of studies that the meta-analyses were accurate within a 2% limit even with exhaustive manual
screening, i.e., using current practice .
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review as topic
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Background
The increasing reliance on evidence provided by system-
atic reviews, coupled with rapidly increasing publishing
rates is leading to an increasing need to automate themore
labor-intensive parts of the systematic review process [1].
Beyond simply reducing the cost involved in producing
systematic reviews, automation technologies, used judi-
ciously, could also help produce more timely systematic
reviews.
For systematic reviews of diagnostic test accuracy
(DTA), no sensitive and specific methodological search fil-
ters are known, and their use is therefore discouraged [2–
4]. Consequently, the number of citations to screen in
a systematic review of diagnostic test accuracy is often
several times higher than for systematic reviews of inter-
ventions, and the need for automation may therefore be
particularly urgent [5–7].
Methods for automating the screening process have
been developed since at least 2006 [8, 9] but have so
far seen limited adoption by the systematic review com-
munity. While there are examples of past and ongoing
systematic reviews using automation, many more use
manual screening. Thomas noted in 2013 that in order
for widespread adoption to occur, screening automation
must not only confer a relative advantage (time saved)
but must also ensure compatibility with the old paradigm,
i.e., ensuring that screening automation is equivalent to
manual screening [10]. There has been a large number of
studies measuring the amount of time saved by automated
screening, which may suggest that automation methods
are maturing in terms of relative advantage. We are how-
ever not aware of any studies focusing on the compati-
bility aspect: whether automated screening results in the
“same” systematic review, and much of the literature to
date have implicitly assumed that recall values over 95%
are both necessary and sufficient to ensure an unchanged
systematic review [8]. In this study, we aim to revisit
this hypothesis, which to our knowledge has never been
tested.
Among possible automation approaches, only screening
prioritization is currently considered safe for use in sys-
tematic reviews [8]. In this approach, systematic review
authors screen all candidate studies, but in descend-
ing order of likelihood of being relevant. It is often
assumed that we can achieve some amount of reduc-
tion in workload by using screening prioritization [8],
but the extent to which this is true has not been evalu-
ated [10]. Screening prioritization can be combined with
a cut-off (stopping criterion) to reduce the workload, for
example, by stopping screening when the priority scores
assigned to remainder of the retrieved studies falls below
some threshold. Using cutoffs is generally discouraged
since it is not possible to guarantee that no relevant
studies remain after the cutoff point and would thus
be falsely discarded [8]. However, using cutoffs would
likely reduce the workload down to a fraction com-
pared to using screening prioritization alone and may
therefore be necessary to fully benefit from screening
prioritization.
Meta-analyses of diagnostic test accuracy
Systematic reviews of diagnostic test accuracy may yield
estimates of diagnostic performance with higher accu-
racy and stronger generalizability than individual studies
and are also useful for establishing whether and how the
results vary by subgroup [11]. Systematic reviews of diag-
nostic test accuracy are critical for establishing what tests
to recommend in guidelines, as well as for establishing
how to interpret test results.
Unlike randomized control trials, which typically report
results as a single measure of effect (e.g., as a relative
risk ratio), diagnostic test accuracy necessarily involves
a trade-off between sensitivity and specificity depend-
ing on the threshold for positivity for the test [11, 12].
Diagnostic test accuracy studies therefore usually report
results as two or more statistics, e.g., sensitivity and
specificity, negative and positive predictive value, or the
receiver operating characteristic (ROC) curve. The raw
data underlying these statistics is called a 2 × 2 table,
consisting of the true positives, the false positives, the
true negatives, and the false negatives for a diagnostic test
evaluation.
Meta-analyses of diagnostic test accuracy pool the 2× 2
tables reported in multiple DTA studies together to form
a summary estimate of the diagnostic test performance.
The results of DTA studies are expected to be heteroge-
neous, and the meta-analysis thus needs to account for
both inter- and intra-study variance [12]. This is com-
monly accomplished using hierarchical random effects
models, such as the bivariate method, or the hierarchi-
cal summary ROC model [13, 14]. Pooling sensitivity and
specificity separately to calculate separate summary val-
ues is discouraged, as it may give an erroneous estimate,
e.g., a sensitivity/specificity pair not lying on the ROC
curve [11].
Systematic reviews require perfect recall
Systematic reviews are typically expected to identify all
relevant literature. In the Cochrane Handbook for DTA
Reviews [4], we can read:
“Identifying as many relevant studies as possible and
documenting the search for studies with sufficient
detail so that it can be reproduced is largely what
distinguishes a systematic review from a traditional nar-
rative review and should help to minimize bias and
assist in achieving more reliable estimates of diagnostic
accuracy.”
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Thus, the requirement to retrieve all relevant literature
may just be a means to achieve unbiased and reliable esti-
mates in the face of, e.g., publication bias, rather than an
end in itself. In this context, “as many relevant studies as
possible” may be better understood as searching multi-
ple sources, including gray literature, in order to mitigate
biases in different databases [4]. Missing a single study in
a systematic review could result in the systematic review
drawing different conclusions, and recall can therefore, in
general, only guarantee an unchanged systematic review
if it is 100%. For some systematic reviews, finding all rele-
vant literature may be the purpose of the review, i.e., when
the review is conducted to populate literature databases
[15]. On the other hand, for systematic reviews addressing
diagnostic accuracy or treatment effects, the review may
be better helped by identifying an unbiased sample of the
literature, sufficiently large to answer the review question
[16]. In systematic reviews of interventions, such a sample
is often substantially larger than can be identified with the
systematic review process [17], but we hypothesize that it
can also be substantially smaller.
Of course, many systematic reviews aim not just to pro-
duce an accurate estimate of the mean and confidence
intervals, but also estimate prevalence, as well as iden-
tify and produce estimates for subgroups. Thus, to ensure
an unchanged systematic review, we would really need to
ensure that the unbiased sample is sufficient to properly
answer all aspects of the research question of the review.
For instance, an unchanged systematic review of diagnos-
tic test accuracy could require unchanged estimates of
summary values, confidence intervals, the identification
of all subgroups, and unchanged estimates of prevalence.
We will in this study restrict ourselves to measuring the
accuracy of the meta-analyses in systematic reviews of
diagnostic test accuracy, i.e., the means and confidence
intervals of the sensitivity and specificity.
There are multiple potential sources of bias that can
affect a systematic review, including publication bias,
language bias, citation bias, multiple publication bias,
database bias, and inclusion bias [18–20]. While some
sources of bias, such as publication bias, mainly occur
across databases, others, such as language bias or citation
bias may be present within a single database.
However, bias (i.e., only finding studies of a certain
kind) is often conflated with the exhaustiveness of the
search (i.e., finding all studies).While an exhaustive search
implies no bias, a non-exhaustive search may be just as
unbiased, provided the sample of the existing literature it
identifies is essentially random. If the goal of the system-
atic review is to estimate the summary diagnostic accu-
racy of a test, the recall (the sensitivity of the screening
procedure) may therefore be less important than the num-
ber of studies or total number of participants identified,
provided the search process does not systematically find,
e.g., English language literature over literature in other
languages. However, previous evaluations of automation
technologies usually measure only recall or use metrics
developed primarily for web searches [6, 7] while side-
stepping the (harder to measure) reproducibility, bias, and
reliability of the parameter estimation process.
The impact of rapid reviews onmeta-analysis accuracy
Screening prioritization aims to decrease the workload
in systematic reviews, while incurring some (presumably
acceptable) decrease in accuracy. Similarly to screening
prioritization, rapid reviews also seek to reduce the work-
load in systematic reviews and produce timelier reviews
by taking shortcuts during the review process and is
sometimes used as an alternative to a full systematic
review when a review needs to be completed on a tight
schedule [21]. Examples of rapid approaches include lim-
iting the literature search by database, publication date,
or language [22].
Unlike screening prioritization, the impact of some
rapid review approaches on meta-analyses have been
evaluated [22–27]. However, a 2015 review identified 50
unique rapid review approaches, and only a few of these
have been rigorously evaluated or used consistently [21].
Limiting inclusion by publication date, excluding smaller
trials, or only using the largest found trial have been
reported to increase risk of changingmeta-analysis results
[22]. By contrast, removing non-English language litera-
ture, unpublished studies, or grey literature rarely change
meta-analysis results [26, 27].
The percentage of included studies in systematic
reviews that are indexed in PubMed has been estimated
between 84–90%, and restricting the literature search to
PubMed has been reported to be relatively safer than
other rapid review approaches [22, 24, 28]. However,
Nussbaumer-Streit et al. have reported 36% changed con-
clusions for randomly sampled reviews, and 11% changed
conclusions for review with at least ten included stud-
ies [23]. The most common change was a decrease in
confidence. Marshall et al. also evaluated a PubMed-only
search for meta-analyses of interventions and demon-
strated changes in result estimates of 5% or more in 19%
of meta-analyses, but the observed changes were equally
likely to favor controls as interventions [22]. Thus, a
PubMed-only search appears to be associated with lower
confidence, but not with consistent bias. Halladay et al.
have reported significant differences between PubMed-
indexed studies and non-PubMed indexed studies in 1
out of 50 meta-analyses including at least 10 studies [24].
While pooled estimates from different database searches
may not be biased to favor either interventions or con-
trols, Sampson et al. have reported that studies indexed in
Embase but not in PubMed not only exhibit consistently
smaller effect sizes, but also reasoned that the prevalence
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of such studies is low enough that this source of bias is
unlikely to be observable in meta-analyses [25].
Related methods for screening prioritization
The earliest known screening prioritization methods
were published in 2006, and a number of methods
have been developed since then [9]. Similar work on
screening the literature for database curation has been
published since 2005 [29, 30]. A wide range of meth-
ods (generally from machine learning) have been used
to prioritize references for screening, including Sup-
port Vector Machines, Naive Bayes, Voting Percep-
trons, LAMBDA-Mart, Decision Trees, EvolutionalSVM,
WAODE, kNN, Rocchia, hypernym relations, ontologies,
Generalized Linear Models, Convolutional Neural Net-
works, Gradient Boosting Machines, Random Indexing,
and Random Forests [6–8, 31]. Several screening prior-
itization systems are publicly available, including EPPI-
Reviewer, Abstrackr, SWIFT-Review, Rayyan, Colandr, and
RobotAnalyst [31–35].
The most straightforward screening prioritization
approach trains a machine learningmodel on the included
and excluded references from previous iterations of the
systematic review, and then uses this model to reduce the
workload in future review updates [8]. For natural reasons,
this approach can only be used in review updates, and not
in new systematic reviews. By contrast, in the active learn-
ing approach, the model is continuously retrained as more
and more references are screened. In a new systematic
review, active learning starts with no training data, and the
process is typically bootstrapped (“seeded”) by sampling
the references randomly, by using unsupervised models
such as clustering or topic modeling or by using informa-
tion retrieval methods with the database query or review
protocol as the query [36].
Comparing the relative performance of different meth-
ods is difficult since most are evaluated on different
datasets, under different settings, and often report dif-
ferent measures. There have been attempts to compare
previous methods by replicating reported methods on the
same datasets, but the replication of published methods is
often difficult or impossible due to insufficient reporting
[37]. Another way to compare the relative performance of
methods is through the use of a shared task, a commu-
nity challenge where participating systems are trained on
the same training data and evaluated blindly using pre-
decided metrics [38, 39]. The shared task model removes
many of the problems of replication studies and also safe-
guards against cheating, mistakes, and the cherry-picking
of metrics or data, as well as publication bias. The only
shared task for screening prioritization we are aware of is
the CLEF Shared Task on Technology-Assisted Reviews in
Empirical Medicine, focusing on diagnostic test accuracy
reviews [6, 7].
The purpose of this study is not to compare the rela-
tive performance of different methods, and we will focus
on a single method (Waterloo CAL) that ranked highest
on most metrics in the CLEF shared task both 2017 and
2018 [6, 7]. As far as we can determine, Waterloo CAL
represents the state of the art for new systematic reviews
of diagnostic test accuracy (i.e., performed de novo). The
training done in Waterloo CAL is also similar to methods
currently used prospectively in recent systematic reviews
and mainly differs in terms of preprocessing [35, 40, 41].
Objectives
Our objectives in this study are twofold:
• We aim to retrospectively and prospectively measure
the impact of screening automation on meta-analysis
accuracy. We will use one single method for analysis
in this study, but the criteria should be usable with any
screening automation method. We will pay special
attention to prospective criteria, since these can also
be calculated while the screening is ongoing, and we
will examine cut-offs for the prospective criteria that
could be used in a prospective setting to bound the
loss in accuracy within prespecified tolerance limits.
• We aim to evaluate the (retrospective) 95% recall
criterion, which has long been the target to strive for
in screening automation, and will test whether this
criterion is necessary and sufficient to guarantee an
unchanged systematic review. In the case the
criterion is not necessary or sufficient, we aim to
develop criteria that could be used instead.
Methods
Data used in the study
The Limsi-Cochrane dataset . This dataset con-
sists of 1939 meta-analyses from 63 systematic
reviews of diagnostic test accuracy from the Cochrane
Library (the full dataset is available online: DOI:
10.5281/zenodo.1303259) [42]. The dataset com-
prises all studies that were included in the systematic
reviews, from any database or from gray literature, as well
as the 2×2 tables (the number of true positives, false pos-
itives, true negatives, and false negatives) extracted from
each included study by the systematic review authors,
grouped by meta-analysis. This dataset can be used to
replicate the meta-analyses in these systematic reviews,
in full or over subsets of the data, for instance, to evaluate
heterogeneity or bias of subgroups.
The CLEF dataset . This dataset consists of all refer-
ences from PubMed considered for inclusion—both those
included in the systematic review and those ultimately
judged not relevant to the systematic review—in 80 sys-
tematic reviews of diagnostic test accuracy also from
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the Cochrane Library (the full dataset is available online:
https://github.com/CLEF-TAR/tar) [6, 7]. Due to the way
the data was collected, this dataset only contains refer-
ences from PubMed, but not from other databases or gray
literature. The dataset only includes the PubMed iden-
tifiers for each reference and whether the studies were
included in the reviews.
Combined dataset . For our experiments, we combined
the two datasets by collecting the reviews, meta-analyses,
and references common to both. In total, this intersection
comprises 48 systematic reviews and 1354 meta-analyses
of diagnostic tests. All analyses in this study will be based
on this intersection unless otherwise specified.
Since the CLEF dataset only includes references from
PubMed, the meta-analyses performed in this study will
only be based on studies from PubMed. Some meta-
analyses may therefore be smaller than they were in the
original reviews. The exclusion of studies from other
sources than PubMed has been demonstrated to have
moderate impact, and no bias on meta-analyses of inter-
ventions, and we will make the explicit assumption that
the same is true for systematic reviews of diagnostic test
accuracy (we are not aware of studies measuring this
directly) [22, 24].
Cochrane guidelines for systematic reviews of diagnos-
tic test accuracy discourage drawing conclusions from
small meta-analyses but do not offer a specific minimum
number of studies required for ameta-analysis [12]. In this
study, we will only consider meta-analyses based on three
or more studies, because the R package we use (mada)
issues a warning when users attempt to calculate summary
estimates based on fewer studies [43]. This minimum
likely errs on the side of leniency.
We considered as meta-analysis any summary estimate
reported individually in the “summary of findings” section
of the systematic reviews, regardless of how the estimates
were calculated. Thus, we considered meta-analyses of
subgroups to constitute distinct meta-analyses, in addi-
tion to any meta-analyses of the entire groups of partic-
ipants. We further considered meta-analyses distinct for
the same diagnostic test evaluated with, e.g., multiple cut-
off values, whenever these are reported separately in the
systematic reviews.
Automated screening method
We used a previously developed active learning approach
to rank all candidate references for each systematic review
in descending order of likelihood of being relevant [44].
The method was selected since it was the best performing
method for new systematic reviews (performed de novo)
in the 2017–2018 Shared Task on Technology Assisted
Reviews of Empirical Medicine [6, 7].
We used this ranking to simulate the literature screening
process in each systematic review, and for those meta-
analyses where at least 3 diagnostic studies were included,
we simulated the meta-analysis continuously throughout
the screening process. As a control, we performed the
same simulation with references screened in random-
ized order. We assumed that screeners will only stop if
prompted to do so by the system. If not prompted to stop,
the screeners will continue screening until all candidate
studies have been screened.
We use a variant of active learning that has demon-
strated good performance in systematic reviews of diag-
nostic test accuracy as well as in article discovery in the
legal domain [45]. In this method, we start with an artifi-
cial training set, where we use the protocol of the review
as an single initial positive training example (seed docu-
ment). This artificial seed document is discarded as soon
as real positive examples are found. We select 100 refer-
ences randomly from the evaluation set and use these as
negative examples, regardless of whether they are really
positive or negative. In each iteration, new “negative”
examples are randomly selected in this way such that the
total number of negative examples is always at least 100.
Following Cormack and Grossman, we show B references
to the screener in each iteration, where B is initially set to
1, then increased by B/10 in each subsequent iteration
[46]. To train, we use logistic regression with stochastic
gradient descent on bigrams and unigrams extracted from
the text in titles and abstracts.
Evolution of a summary estimate
We define the effort in a screening process as the number
of candidate studies screened so far. Thus, we will for sim-
plicity assume that screening a single article will always
incur the same cost.
To measure the reliability of a summary estimate, we
define the loss at each timestep as the absolute dis-
tance to its “true” value, similarly to previous work on
the evolution of heterogeneity estimates by Thorlund
et al. [47]. To obtain a scalar loss score for a sensitiv-
ity/specificity pair, we use the euclidean L2 distance to
the true value. That is, given a true sensitivity/specificity
(μ, ν), then for any estimate (μˆ, νˆ), we define its L2
loss as
L2(μˆ, νˆ) =
√
(μ − μˆ)2 + (ν − νˆ)2
Similarly to Thorlund et al., we used the final estimate
over all relevant studies as a good approximation of the
“truth” [47]. This however assumes that the number of
relevant studies is sufficiently large that the final summary
estimates have converged and are stable.
Conventionally, the screening process first identifies all
relevant studies, and the summary estimates are only
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estimated after the screening process has finished. How-
ever, nothing prevents systematic review authors from
calculating an estimate as soon as someminimumnumber
of studies have been identified, and then recalculate this
estimate every time a relevant article is discovered (see
Figs. 1–2). Continuously updated, we should expect the
estimate to be unreliable at first, but converge to its true
value, and equivalently, the loss to approach zero.
Finding a balance between loss and effort
To search for an optimal balance between loss and effort,
we consider two types of stopping criteria, retrospective
and prospective.
Retrospective stopping criteria (cutoffs) are evaluated
on the effort/loss curve (Figs. 1–2) or using other infor-
mation only available after screening has finished, and
these criteria can therefore only be applied retrospectively.
While we cannot use these criteria to decide when to
stop the screening, we can use them for evaluation, i.e.,
to retrospectively see where we could theoretically have
interrupted screening without impacting the accuracy of
the summary estimate.
Prospective stopping criteria can be evaluated with-
out knowing the final estimates or the total number of
relevant studies among the candidates and can there-
fore be used for decision support in a live systematic
review.
Retrospective stopping criteria
Recall (R) The recall, or the sensitivity of the screening
procedure, measures what fraction of the relevant studies
were identified by the screening procedure. Commonly,
only very high values are considered acceptable (R = 95%
and R = 100%), but values as low as R = 55% have been
considered [48].
This is one of the only measures commonly used in pre-
vious literature [8] and forms the basis for evaluationmea-
sures such as WSS@95 [9]. Common performance metrics
such as WSS@95 evaluates the theoretical workload reduc-
tion if screening were somehow to be interrupted after
identifying 95% of all relevant studies. However, it is not
possible to know when this point has been reached dur-
ing a systematic review, since it is not possible to know the
number of relevant studies before screening all references.
Knee/elbow method We here stop at the “elbow” point
on the effort/loss curve (Fig. 3). This is a point on the
curve corresponding to the optimal point in terms of
balance between effort and estimated precision.
Multiple definitions of the elbow point exist. We here
use the definition due to Satopää et al. [49], which is easy
to implement and robust against noise. Under this defi-
nition, the knee point on the effort/gain curve is the one
furthest from a straight line drawn from the first and last
points on the curve.
Fig. 1 Example of effort/loss curve for a single meta-analysis using screening prioritization. The evolution of the sensitivity and specificity estimates
for one diagnostic test “CD008803 1 GDx: inferior average” (n = 48), where the candidate studies are screened using screening prioritization. The
x-axis measures the number of screened studies (effort) and the the y-axis measures the summary estimates at the 25%, 50%, and 75% percentiles
over 20 simulated screenings using screening prioritization. We also plot the difference to the “true” values (bottom)
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Fig. 2 Example of effort/loss curve for a single meta-analysis using randomized order. The evolution of the sensitivity and specificity estimates for
one diagnostic test “CD008803 1 GDx: inferior average” (n = 48), where the candidate studies are screened in arbitrary order. The x-axis measures
the number of screened studies (effort) and the the y-axis measures the summary estimates at the 25%, 50%, and 75% percentiles over 400
simulated screenings using arbitrary (pseudorandom) order. We also plot the difference to the “true” values (bottom)
Fig. 3 The elbow algorithm and the slope criterion
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Loss/effort We here stop at the point on the effort/loss
curve where we would have needed to screen at least
E references to further reduce the L2 loss by at least 
(Fig. 3).
This corresponds to the first consecutive pair of points
(et−1, λt−1), (et , λt) on the convex hull of the effort/loss
curve such that
losst
effortt
= λt
et
= λt − λt−1et − et−1 > −

E
Since we can only calculate the loss after the screening
has finished, we can only apply the criterion retrospec-
tively in this study.
The same stopping criterion has been used in simi-
lar applications, for instance, for determining when all
themes have been identified in ecological surveys [50].
However, the effort/loss curve does not move in only one
direction, since adding a single study frequently shifts the
estimate away from the truth. Whenever this happens,
λt
et will change signs and immediately trigger the condi-
tion. To prevent this from happening, we take the convex
hull of the curve, which makes the curve monotonously
decreasing.
Prospective stopping criteria
Number of relevant studies retrieved We here stop as
soon as we have identified n relevant studies.
Found/effort This criterion is conceptually similar to the
loss/effort criterion, except that we use the number of rel-
evant studies found instead of the loss.We here stop at the
point where we have to screen at least E references to find
F additional relevant studies [50].
This corresponds to the first consecutive pair of points
(et−1, ft−1), (et , ft) on the the found/effort curve such that
foundt
effortt
= ft
et
= ft − ft−1et − et−1 <
F
E
Unlike the loss/effort, the number of found relevant
studies is monotonously increasing and we therefore do
not need to take the convex hull of the found/effort curve.
This criterion is equivalent to stopping when we have
not encountered a new relevant study among the last
E/F candidate studies screened, and the criterion will
therefore always incur a constant effort penalty equal to
E/F .
Displacement Every time we identify an additional rel-
evant study, we calculate how much the sensitivity and
specificity estimates change when the study is included
in the meta-analysis. That is, if two consecutively iden-
tified relevant studies were identified at time steps t and
t − 1, and st = (μt , νt) and st−1 = (μt−1, νt−1) are
the summary estimates of sensitivity and specificity at
these time points, then we define the displacement at
time t as
λt =
√
(μt − μt−1)2 + (νt − νt−1)2
To make the results less sensitive to noise, we will mainly
consider the moving average (MA) of the displacement
with window size 2 (abbreviated MA2).
This criterion can only be calculated if a summary esti-
mate can be calculated and is therefore undefined until at
least three relevant studies have been found.
Displacement (loocv) For any set of of references, we
calculate the leave-one-out cross-validated (LOOCV) [51]
displacement as the median displacement when excluding
each reference from the summary estimate calculations.
That is, consider that a set of studies S has been identi-
fied at some point in the screening process, where (μ, ν) is
the summary estimate that would result when calculated
based on all studies in S. Further, let (μs, νs) be the sum-
mary estimate that would result from excluding a single
study s ∈ S. Then, we define the LOOCV displacement as
λS = medians∈S
[√
(μ − μs)2 + (ν − νs)2
]
This criterion can only be calculated if a summary esti-
mate can be calculated and is therefore undefined until at
least three relevant studies have been found.
Calculation of summary statistics
To calculate the summary estimates, we used the
reitsma function from the mada R package [43],
which implements the Reitsma bivariate random effects
model [13].
Results
Characteristics of the systematic reviews
In the 63 systematic reviews in the Limsi-Cochrane
dataset, the minimum number of meta-analyses was 1 (3
reviews), the mode was 2 (11 reviews), the median was 6,
and the maximum was 170.
We used the combined dataset for all analyses. This
dataset comprises 48 systematic reviews and 1354 meta-
analyses of diagnostic test accuracy, but only 400 of the
meta-analyses were based on at least 3 primary studies in
PubMed and thus included in our analysis. Ninety-six of
the meta-analyses were based on ten or more studies in
PubMed. While we only consider studies from PubMed
in this study, which decreases the number of studies per
meta-analysis, the large majority of meta-analyses in the
original systematic reviews were based on only one or two
studies collected from multiple databases [42].
The small size of the meta-analyses were reflected in
the number of times the stopping criteria triggered. With
cutoff set to 1 relevant per 500 screened, the found/effort
criterion would have triggered for 277/400 meta-analyses
Norman et al. Systematic Reviews           (2019) 8:243 Page 9 of 18
and for all meta-analyses in 30/48 systematic reviews
(ranked, found/effort (1/500) in Table 1). With cutoff set
to 1 relevant per 2000 screened, it would have triggered
for 174/400 meta-analyses and for all meta-analyses in
17/48 systematic reviews (ranked, found/effort (1/2,000)
in Table 1). With cutoff set to 0.02, the displacement cri-
terion would have triggered for 91/400 meta-analyses or
for all meta-analyses in 4/48 systematic reviews (ranked,
displacement MA2 (0.02) in Table 1). With cutoff set to
0.005, it would have triggered for 35/400 meta-analyses
and for all meta-analyses in no systematic review (ranked,
displacement MA2 (0.005) in Table 1).
Howmany studies does it take to make a meta-analysis?
The displacement when including the last relevant study
in the meta-analyses decreases with the total number n of
studies included in the meta-analysis (Fig. 4). The last pri-
mary study added to the summary estimate calculations
displace the estimates by 16 percentage points or less for
n ≥ 5, by 4 points or less for n ≥ 10, by 2 points or less for
n ≥ 20, and by 1 points or less for n ≥ 50.
There is a moderately strong correlation (Pearson r =
0.54) between the last displacement and the L2 loss at each
summary estimate update. The correlation can be made
somewhat stronger by taking the moving average over the
last few successive summary estimate updates to cancel
out some of the spurious values (MA2: r = 0.59, MA3:
r = 0.60, MA4: r = 0.59, MA5: r = 0.58). Averag-
ing the displacement using leave-one-out cross-validation
[51] gives similar correlation to MA3 (r = 0.60).
Contribution of screening prioritization
Screening prioritization requires screening a much
smaller number of candidate references to reach the cutoff
point for all criteria, particularly for prospective criteria.
For instance, identification of at least ten relevant pri-
mary studies for each applicable meta-analysis would be
reached after screening an average of 4.4% of the candi-
date studies, while we would have needed to screen an
average of 53.7% of the candidate studies in randomized
order to achieve the same (relevant found (n = 10) in
Table 1). To identify 20 relevant studies for each meta-
analysis, it would have been necessary to screen an average
of 57.4% of the references in random order, but only 5.0%
using screening prioritization (relevant found (n = 20) in
Table 1).
For all criteria except the found/effort, the estimation
error is similar at the cutoff point for prioritized screening
and screening in random order.
On average, the displacement threshold criterion and
the number of relevant found exhibit roughly similar
behavior in terms of accuracy and efficiency. In Table 1, we
see that if we stop after finding ten relevant studies (cri-
terion: “relevant found (n = 10)”), we would misestimate
the mean sensitivity by approximately 2.4 percentage
point and the mean specificity by approximately 1.3 per-
centage point. If we stop after observing a mean 0.02
displacement over the last two updates (criterion: “dis-
placement MA2 (0.02)”), we would also have needed to
screen 4.4% of the candidate studies on average, and we
would have misestimated the mean sensitivity by approx-
imately 2.4 percentage point and the mean specificity by
1.0 percentage point.
Stricter thresholds allow trading a higher screening
workload for lower estimation error. For instance, stop-
ping after finding 20 relevant studies (criterion: “rel-
evant found (n = 20)”) leads to screening 5.0% of
the candidate studies on average and misestimates the
mean sensitivity by approximately 2.0 percentage point
and the mean specificity by approximately 0.7 percent-
age point. Similarly, stopping after observing a mean
0.005 displacement over the last two updates (criterion:
“displacement MA2 (0.005)”) leads to screening 8.6% of
the candidate studies on average and misestimates the
mean sensitivity by approximately 1.2 percentage point
and the mean specificity by approximately 0.7 percentage
point.
However, while the average discrepancy is only 2 per-
centage point, the results vary greatly between meta-
analyses, and the discrepancy for a given meta-analysis
may be as high as 8 percentage point, even with a conser-
vative threshold (Fig. 5).
Discussion
Bymonitoring themoving average of the displacement, we
were able to estimate the current precision of the diagnos-
tic test accuracy estimates through the screening process.
However, the meta-analyses of diagnostic test accuracy
were accurate within 2% only for meta-analyses including
at least 20 studies (Fig. 4). A criterion to interrupt screen-
ing once the displacement falls below 2% would conse-
quently have triggered in 91/400 meta-analyses (Table 1).
Many meta-analyses had poor accuracy even when based
on all relevant studies (Fig. 4).
Estimates converge faster using screening prioritization
Screening prioritization identifies most or all relevant
primary studies much earlier in the screening process
compared to randomized order (Fig. 5). The rate of iden-
tification of relevant studies will generally be high ini-
tially, before dropping down to a trickle. This rate can
be used either to estimate how many relevant studies
exist among the candidates [45] or directly as a stopping
criteria (cf. found/effort in Table 1). When screening in
randomized order, the gaps between successive relevant
studies is likely to be large, with highly variable size, which
makes it more difficult to estimate the identification rate
or the total number of relevant studies. Consequently,
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Table 1 Average measured loss for each criterion, measured for all tests where the criteria triggered
Triggered Effort Recall L2 loss Sensitivity loss Specificity loss
Criterion type Criterion MA SR abs perc mean lb ub mean lb ub
Ranked
Retrospective Recall (95%) 41 1 5494.122 0.489 0.960 0.001 0.001 0.001 0.001 0.000 0.000 0.000
Knee/elbow 314 30 120.752 0.047 0.299 0.056 0.040 0.174 0.086 0.029 0.221 0.038
Loss/effort (0.02/1000) 314 30 259.570 0.104 0.527 0.023 0.018 0.140 0.053 0.010 0.170 0.026
Loss/effort (0.015/1000) 314 30 271.589 0.108 0.539 0.022 0.018 0.136 0.052 0.009 0.168 0.025
Loss/effort (0.01/1000) 314 30 297.064 0.113 0.546 0.021 0.016 0.136 0.049 0.009 0.166 0.023
Prospective Found/effort (1/500) 277 30 811.220 0.268 0.770 0.012 0.008 0.011 0.014 0.006 0.020 0.003
Found/effort (1/1000) 254 22 1338.465 0.386 0.783 0.007 0.005 0.006 0.005 0.003 0.007 0.002
Found/effort (1/2000) 174 17 2330.448 0.424 0.815 0.002 0.002 0.002 0.002 0.001 0.002 0.000
Relevant found (n = 20) 41 1 162.732 0.050 0.565 0.023 0.020 0.026 0.022 0.007 0.014 0.008
Relevant found (n = 15) 57 3 140.000 0.039 0.534 0.029 0.024 0.029 0.026 0.010 0.020 0.011
Relevant found (n = 10) 96 4 109.042 0.044 0.529 0.031 0.024 0.039 0.028 0.013 0.027 0.014
Displacement MA2 (0.005) 35 0 344.714 0.086 0.667 0.014 0.012 0.015 0.012 0.005 0.011 0.005
Displacement MA2 (0.010) 57 2 280.000 0.065 0.578 0.018 0.016 0.021 0.018 0.005 0.013 0.008
Displacement MA2 (0.015) 74 3 205.189 0.059 0.538 0.024 0.019 0.030 0.021 0.008 0.018 0.012
Displacement MA2 (0.020) 91 4 124.099 0.044 0.511 0.029 0.024 0.034 0.025 0.010 0.022 0.013
Displacement LOOCV (0.005) 42 0 131.667 0.050 0.538 0.021 0.019 0.030 0.016 0.006 0.017 0.008
Displacement LOOCV (0.010) 90 3 192.356 0.054 0.461 0.030 0.026 0.038 0.025 0.010 0.021 0.013
Displacement LOOCV (0.015) 130 5 161.923 0.063 0.427 0.035 0.028 0.042 0.030 0.013 0.029 0.015
Displacement LOOCV (0.020) 152 5 172.947 0.053 0.370 0.042 0.034 0.054 0.034 0.016 0.033 0.019
Randomized
Retrospective Recall (95%) 36 1 6956.583 0.961 0.959 0.002 0.002 0.002 0.002 0.000 0.001 0.000
Knee/elbow 314 30 1658.322 0.299 0.203 0.064 0.042 0.208 0.103 0.039 0.228 0.051
Loss/effort (0.02/1000) 309 27 1315.816 0.351 0.264 0.047 0.036 0.269 0.101 0.022 0.333 0.049
Loss/effort (0.015/1000) 309 27 1429.359 0.364 0.285 0.043 0.033 0.249 0.097 0.020 0.309 0.046
Loss/effort (0.01/1000) 309 27 1552.871 0.390 0.313 0.040 0.030 0.237 0.093 0.018 0.299 0.043
Prospective Found/effort (1/500) 218 16 1854.106 0.374 0.169 0.112 0.073 0.329 0.143 0.063 0.418 0.061
Found/effort (1/1000) 151 10 2942.583 0.465 0.237 0.097 0.062 0.268 0.113 0.055 0.338 0.045
Found/effort (1/2000) 68 6 5097.559 0.493 0.272 0.082 0.052 0.239 0.083 0.042 0.294 0.022
Relevant found (n = 20) 41 1 5106.000 0.574 0.565 0.022 0.018 0.023 0.021 0.008 0.013 0.010
Relevant found (n = 15) 57 3 4288.070 0.550 0.534 0.024 0.020 0.026 0.025 0.010 0.015 0.013
Relevant found (n = 10) 93 4 3275.194 0.537 0.517 0.032 0.024 0.039 0.028 0.015 0.025 0.016
Displacement MA2 (0.005) 33 0 6478.970 0.663 0.644 0.016 0.014 0.017 0.014 0.006 0.011 0.009
Displacement MA2 (0.010) 54 2 4395.889 0.537 0.519 0.023 0.019 0.027 0.021 0.009 0.016 0.012
Displacement MA2 (0.015) 74 3 4103.730 0.533 0.505 0.025 0.021 0.030 0.023 0.010 0.017 0.011
Displacement MA2 (0.020) 87 4 3478.276 0.509 0.485 0.026 0.022 0.034 0.024 0.010 0.020 0.013
Displacement LOOCV (0.005) 40 1 5525.525 0.557 0.537 0.017 0.014 0.020 0.014 0.008 0.014 0.007
Displacement LOOCV (0.010) 87 3 3928.483 0.498 0.454 0.027 0.022 0.037 0.022 0.009 0.022 0.011
Displacement LOOCV (0.015) 130 4 2902.831 0.475 0.415 0.038 0.031 0.048 0.030 0.014 0.032 0.015
Displacement LOOCV (0.020) 154 5 2808.455 0.453 0.396 0.041 0.035 0.051 0.034 0.014 0.035 0.016
Triggered signifies the number of meta-analyses (MA, maximum 400) for which the criterion triggered and the number of systematic reviews (SR, maximum 48) where the
criterion triggered for all meta-analyses. Effort signifies the absolute and relative number of references needed to be screened before triggering the stopping criteria. Recall
signifies the percentage of relevant studies identified when the stopping criterion triggered. The loss in sensitivity and specificity are measured as the difference to the final
estimates at the criterion threshold. We also include the the difference between the measured lower and upper bounds of the 95% confidence intervals and their final
estimated values (lb, ub)
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Fig. 4 Displacement versus number of relevant primary studies The x-axis denotes how much the estimate changed when the last relevant primary
study was included (L2 distance between successive sensitivity/specificity pairs). The y-axis denotes the total number of relevant primary studies
found for the diagnostic test
the found/effort criterion interrupts too prematurely in
randomized order leading to higher loss for sensitivity,
specificity, and their associated confidence intervals, for
all evaluated cutoffs (Table 1, bottom section).
We can also observe that the summary estimates con-
verge to their final values much more quickly and reliably
than when screening in arbitrary order (Figs. 1 and 2).
In other words, screening prioritization allows producing
almost the same estimates with reduced effort—the
problem is knowing whether it is safe to interrupt the
screening prematurely. However, screening prioritization
may allow meta-analyses to be started after screen-
ing a few percent of the candidate references. Even if
the authors of the systematic review decide that all
references need to be screened to ensure that noth-
ing is missed, the meta-analysis may be conducted in
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Fig. 5 Comparisonbetweenstoppingcriteriaeffort (y-axis) versus L2 distancetofinal summaryestimate (x-axis) for each stopping criteria in themeta-analyses.
We only included meta-analyses based on at least 20 studies, so that the criteria were applicable to all meta-analyses and consequently that all data
points occur in all scatterplots. This is limited by the relevant found criterion, which only makes sense for meta-analyses based on at least 20 studies
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parallel with screening the remaining references and can
later be updated to account for any additional studies
found.
Sufficiently large meta-analyses can be stopped
prematurely
For any individual summary estimate, we can have two
outcomes:
1 The systematic review fails to identify sufficient
evidence, and the estimates produced by the
published systematic review may in fact be biased or
unreliable due to the insufficient amount of evidence.
2 The estimate is unbiased and reliable at some point
in the screening process. Continuing the screening
process is unlikely to change the precision of the
estimate (cf. Fig. 1), and the effort could arguably be
spent elsewhere.
The systematic review process implicitly assumes the
borderline case between these two, where the estimate
becomes unbiased and reliable only and exactly at the
end of the screening. Our results suggest this may not
be an unreasonable assumption when screening in ran-
dom order—the displacement fell below a tolerance of 0.1
only during the last 10% of the screened references for 10
out of 41 meta-analyses based on at least 10 studies (ran-
dom, displacement threshold (0.01) in Fig. 5). However,
the same was only true for 1 out of 41 meta-analyses when
using ranked order (ranked, displacement threshold (0.01)
in Fig. 5).
In case 1, we could arguably stop screening (and pos-
sibly refine the database search) as soon as it becomes
clear that a sufficient number of relevant studies cannot
be retrieved.We cannot knowwith absolute certainty how
many remaining studies exist for us to find. However, the
found/effort curve will typically be convex when the can-
didate list is ranked, and extrapolating from its current
slope therefore provides a probabilistic upper bound of
the number of remaining studies [45].
Case 2 assumes a sufficiently large amount of evidence
to base the summary estimates upon. Then, as additional
evidence is accumulated, the summary estimate will con-
verge to its true value. The value of additional evidence
will drop accordingly as the estimate becomes increasingly
stable.
We previously estimated the average discrepancy when
replicating summary estimates in the systematic reviews
at approximately 2 percentage point [42], and we can take
this as a minimum requirement for estimation accuracy.
On average, we can achieve the same or better estima-
tion accuracy with the displacement criterion with a cutoff
of 0.01 or lower or with the found/effort criterion with a
cutoff of 1/500 or lower.
Data saturation is seldom reached in DTA systematic
reviews
We observe a consistent positive relationship between
meta-analysis size and the accuracy of the estimates
(Fig. 4). The least accurate diagnostic test accuracy esti-
mates occurred for meta-analyses of three included stud-
ies and were accurate only within roughly 50% of their
final values (Fig. 4). The vast majority of estimates were
not accurate within 2% at the end of the screening process.
These results mirror the work of Wetterslev et al, who
have previously observed that most Cochrane systematic
reviews of interventions are insufficiently powered to even
detect or reject large intervention effects [17]
Our stopping criteria based on displacement will only
interrupt the screening process once the estimates have
stabilized due to data saturation. If data saturation fails to
occur because too few studies exist to find, the screen-
ing will not be interrupted.We can however also interrupt
screening if it becomes clear that no further studies will
be uncovered by the screening process, i.e., by using a
stopping criterion like found vs effort.
For instance, using a combination of stopping criteria
(displacement (0.01) OR relevant (n = 15) OR found/effort
(1/1000)) would have reduced the screening effort by
21.5–99.9285% (mean 81.7%, median 90.56%) for themain
meta-analysis in 33 out of 38 systematic reviews with an
average 1.2% estimation error (Fig. 6). The five system-
atic reviews where the effort would not have been reduced
were among the smallest with a total number of candidate
studies ranging from 64 to 981. Ten systematic reviews
performed no meta-analysis with at least three studies in
PubMed and were therefore excluded from this analysis.
External validity
We have presented seven criteria and have evaluated how
these perform when using logistic regression for ranking
and when using random order. We expect these criteria to
generalize differently if used with other methods.
The L2 loss guarantees presented for the recall, the rel-
evant found, and the displacement (either with MA2 or
LOOCV) only depend on the relative order of the relevant
studies and is otherwise independent of where in the rank-
ing the relevant studies occur. In other words, whether
our results for these criteria extend to other methods only
depends on how the method orders the relevant studies.
In this study, we demonstrate that using these criteria with
logistic regression results in the same L2 loss compared to
random order, and thus that logistic regression does not
bias themeta-analyses compared to random order. In light
of this, we expect these criteria to yield similar L2 loss for
any ranking method that is similarly unbiased.
The knee/elbow criterion, the loss/effort criterion, and
the found/effort criterion all depend on the relative order
of all studies, both relevant and non-relevant, and can
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Fig. 6 The impact of screening prioritization and stopping criteria on meta-analyses. Difference in meta-analysis results for the largest meta-analysis
in each systematic review using a combination of stopping criteria (displacement (0.01) OR relevant (n = 15) OR found/effort (1/1000)). Ten
systematic reviews did not include any meta-analysis based on three or more studies (in PubMed) and were therefore excluded from the results.
Effort denotes the fraction of candidate references screened. Recall denotes the fraction of identified relevant studies. Blue data points correspond
to the simulated results using early stopping. Red data points correspond to results without early stopping, i.e., equivalent to current practice (which
would have 100% effort and 100% recall)
therefore be expected to give different results depending
on the strength of the ranking method. We can observe
this in Fig. 5, where the knee/elbow criterion and the
loss/effort criterion result in larger and more frequent
L2 losses for random order than for ranked order. The
found/effort criterion breaks down entirely for random
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order and yields unacceptably large L2 losses (see random-
ized: found/effort in Table 6). In light of this, the param-
eters we use for these criteria thus cannot be assumed
to yield the same L2 losses for other ranking methods
and would need to be recalibrated when used with other
methods.
In this study, we have only considered meta-analyses
with at least three included studies. However, the prospec-
tive criteria are conservative and will simply not trigger
when used in a systematic review where there are only
two or less studies to find. The only exception is the
found/effort criterion, but this criterion can easily be
modified so that it is ignored before at least three relevant
studies have been found.
Recommendations
We explicitly refrain from recommending specific stop-
ping criteria or specific cutoff values, since there is no one
size that fits all systematic reviews—the criteria and their
parameters need to be decided to suit the purposes of the
review. If automation is adopted in a systematic review,
acceptable tolerances should be decided as part of the pro-
tocol, and the protocol should include a strategy to ensure
that the tolerance criteria will be satisfied.
We recommend that several stopping criteria be mon-
itored in parallel and that screening is interrupted only
once criteria for all necessary aspects of the systematic
review are satisfied. In this study, we focus on the accu-
racy of the main meta-analysis—similar criteria should
also be specified for all other aspects deemed necessary
for the review, such as the identification of all subgroups
or estimates of prevalence of the diagnosed condition.
Specifically, to monitor the accuracy of the sensitivity
and specificity estimates, we recommend the use of:
• The displacement MA2 criterion, set to half the
required tolerance
• The displacement LOOCV criterion, set to half the
required tolerance
• The relevant found criterion, set convervatively (15 at
a minimum)
TheMA2 and LOOCV displacement yield similar infor-
mation and do not need to be monitored simultane-
ously. The LOOCV variant underestimated the loss in our
experimentsmore than theMA2 and triggeredmore often
with larger average L2 loss, and we therefore recommend
the MA2 variant over LOOCV. On average, both variants
overestimated the final L2 loss and we recommend the
displacement be interpreted with this in mind.
These criteria triggering mean that the current estimate
is accurate within a given tolerance and that further stud-
ies are unlikely to change the estimates, even if a large
number of relevant studies still exist to find. These criteria
can also be used with randomized screening and likely
also for any screening prioritization method that does
not bias the order of the relevant studies. If the displace-
ment criterion is infeasible to calculate, the relevant found
criterion can be used alone, but it may be difficult to
infer meta-analysis accuracy from the number of relevant
studies included.
• The loss/effort criterion with a conservative
parameter setting (1/1000 or stricter)
This criterion triggering is an indication that no fur-
ther studies exist to find. This criterion should be treated
with more caution than the other criteria. In particular,
the criterion depends on the strength of the screening pri-
oritization method and can trigger prematurely, e.g., if the
method struggles to find some subset of the relevant stud-
ies or if the screening prioritization method is generally
poor.
The found/effort criterion is also more likely to trigger
prematurely if the total number of relevant studies is low.
Therefore, we also recommend not using this criterion
until some minimum number of studies have been identi-
fied (three appear to be a safe choice for the current setting
and the current method).
Limitations of this study
This study focused on systematic reviews of diagnostic
test accuracy studies. Therefore, we do not know what
the implications are for other types of systematic reviews.
However, the methods in this study are applicable to
systematic reviews estimating numerical values, and our
results may therefore be applicable also to systematic
reviews of interventions.
Due to the nature of the datasets, we could only recal-
culate meta-analyses using data from studies indexed
in PubMed. Previous studies examining the impact of
only searching PubMed on meta-analyses of interven-
tions demonstrated moderate changes in estimates, and
observed changes were equally likely to favor controls
as interventions [22, 24]. In this study, we assume that
searching only PubMed is similarly unbiased for diagnos-
tic test accuracy, but we are aware of no studies examining
this directly. Limiting the meta-analyses to PubMed does
however reduce the number of studies available for anal-
ysis and may therefore mean that we are underestimating
the applicability of these stopping criteria and that we
may be observing greater variance than we would in a
prospective setting.
This study focused on Cochrane systematic reviews,
which are known to have higher consistency and lower
bias than other systematic reviews [52]. It is not clear what
the implications are for systematic reviews conducted
with less stringency than Cochrane systematic reviews.
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The definition of loss we use for evaluation (L2) makes
the simplifying assumption that sensitivity and specificity
are equally important. Specificity values of diagnostic
tests tend towards values close to one and thus often
exhibit smaller variance than the sensitivity. As a result,
the L2 loss is often dominated by the sensitivity loss
(Table 1). We also report loss separately for sensitivity and
specificity in our analysis.
Future work
Future work will evaluate the validity of these results in
prospective settings. We also plan to use Bayesian meth-
ods to estimate final meta-analysis accuracy from the
study data accumulated through the screening process.
Furthermore, we will also aim to extend this approach to
other study types beyond diagnostic test accuracy, such as
intervention studies.
Conclusions
Our results suggest that diagnostic summary sensitiv-
ity and specificity can be estimated within an accuracy
of 2 percentage points while deliberately missing over
40% of the relevant studies within a single database.
This is contrary to current guidelines which assume
that an exhaustive search is necessary to produce reli-
able estimates with low bias. On the other hand, we
find a clear relationship between the absolute size of
the meta-analysis and the reliability and precision of
the estimates. In other words, a reliable meta-analysis
requires identifying a sufficient number of studies, but
how large a fraction of relevant studies is identified is less
important.
In the simulations, a combination of stopping criteria
reduced the screening effort by 71.2% on average (median
86.8%, range 0% to 99.93%) for the main meta-analysis in
each systematic review and triggered in every systematic
reviewwithmore than 1000 candidate studies. No system-
atic review required screening more than 2,308 studies,
whereas exhaustive manual screening required screening
up to 43,363 studies. Despite an average 70% recall, the
estimation error was 1.3% on average, much less than
the estimation error expected when replicating summary
estimate calculations.
The (retrospective) 95% recall criterion yielded an
average 0.1% error when ranking with logistic regres-
sion and an average 0.2% error when using random
order. Thus, we confirm the hypothesis that 95% recall
is sufficient to accurately estimate the main meta-
analysis in systematic reviews of diagnostic test accu-
racy, provided the ranking method is unbiased. On
the other hand, we observe almost unchanged esti-
mates (within 2% tolerance) for recall as low as 30%,
and 95% recall is thus not necessary to reach accurate
estimates.
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